Dialogue with Chang Yan, President of Enotris
Time：
2026-05-26 08:09
Author：
xieyiju
CPIC 2026 | A Mysterious Guardian Debuts! Name It and Win Prizes – Sponsors Welcome!
Awaiting a Name, Embarking on a Journey
Time：
2026-05-24 21:41
Author：
xieyijun
In 2026, brain-computer interfaces go viral.
Time：
2026-05-24 21:32
Author：
xieyijun
CPIC 2026 | Over 100 Companies Have Secured Booths – Come See Who They Are!
Find Partners, Discover Products, Connect Resources – All at One Stop
Time：
2026-05-22 22:33
Author：
xieyijun
In Vivo CAR-T: Capital Has Arrived, But Has Efficacy?
Time：
2026-05-22 22:27
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务